| |
|
PBC | Abstract Library |
 |
| |
| The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors. |
|
|
| |
| 2. | Protein and miRNA profile of circulating extracellular vesicles in patients with primary sclerosing cholangitis |
| |
Sci Rep. 2022 Feb 22;12(1):3027. doi: 10.1038/s41598-022-06809-0.
Davide Povero # 1, Masahiko Tameda # 2, Akiko Eguchi 2, Wenhua Ren 3, Jihoon Kim 4, Robert Myers 5, Zachary D Goodman 6, Stephen A Harrison 7, Arun J Sanyal 8, Jaime Bosch 9 10, Lucila Ohno-Machado 4, Ariel E Feldstein 11
|
|
| |
|
|
| |
|
|
| |
| 5. | A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis |
| |
J Hepatol. 2022 Mar 30;S0168-8278(22)00187-8. doi: 10.1016/j.jhep.2022.02.033.Online ahead of print.
Christopher L Bowlus 1, Michael R Galambos 2, Richard J Aspinall 3, Gideon M Hirschfield 4, David E J Jones 5, Yvonne Dörffel 6, Stuart C Gordon 7, Stephen A Harrison 8, Andreas E Kremer 9, Marlyn J Mayo 10, Paul J Thuluvath 11, Cynthia Levy 12, Mark G Swain 13, Guy W Neff 14, David A Sheridan 15, Carmen M Stanca 16, Christoph P Berg 17, Aparna Goel 18, Mitchell L Shiffman 19, John M Vierling 20, Pol Boudes 21, Alexandra Steinberg 21, Yun-Jung Choi 21, Charles A McWherter 21
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 10. | Ethnicity, disease severity and survival in Canadian patients with Primary Biliary Cholangitis |
| |
Hepatology. 2022 Feb 26. doi: 10.1002/hep.32426. Online ahead of print.
Surain B Roberts 1 2, Gideon M Hirschfield 1 2, Lawrence J Worobetz 3, Catherine Vincent 4, Jennifer A Flemming 5, Angela Cheung 6, Karim Qumosani 7, Mark Swain 8, Dusanka Grbic 9, Hin Hin Ko 10, Kevork Peltekian 11, Nazia Selzner 12, Lusine Abrahamyan 2 12, Bishoi Aziz 13, Ellina Lytvyak 13, Kattleya Tirona 1, Aliya F Gulamhusein 1 2, Harry LA Janssen 1, Aldo J Montano-Loza 13, Andrew L Mason 13, Bettina E Hansen 1 2, Canadian Network for Autoimmune Liver disease (CaNAL)
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 15. | Evaluation of Inhibitory Antibodies against the Muscarinic Acetylcholine Receptor Type 3 in Patients with Primary Biliary Cholangitis and Primary Sclerosing Cholangitis |
| |
Clin Med. 2022 Jan 28;11(3):681. doi: 10.3390/jcm11030681.
Anne-Christin Beatrice Wilde 1, Lena Maria Greverath 1, Lara Marleen Steinhagen 1, Nina Wald de Chamorro 1, Elise Leicht 1, Janett Fischer 2, Toni Herta 2, Thomas Berg 2, Beate Preuss 3, Reinhild Klein 3, Frank Tacke 1, Tobias Müller 1
|
|
| |
| 16. | Elastography improves accuracy of early hepato-biliary complications diagnosis after allogeneic stem cell transplantation |
| |
Haematologica. 2021 Sep 1;106(9):2374-2383. doi: 10.3324/haematol.2019.245407.
Pierre-Edouard Debureaux 1, Pierre Bourrier 2, Pierre-Emmanuel Rautou 3, Anne-Marie Zagdanski 2, Morgane De Boutiny 2, Simona Pagliuca 1, Aurélien Sutra Del Galy 1, Marie Robin 1, Régis Peffault de Latour 1, Aurélie Plessier 4, Flore Sicre de Fontbrune 1, Aliénor Xhaard 1, Pedro Henrique de Lima Prata 1, Dominique Valla 3, Gérard Socié 1, David Michonneau 1
|
|
| |
|
|
| |
| 18. | Management of primary biliary cholangitis: results from a large real-life observational study in France and Belgium |
| |
Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e197-e205.doi: 10.1097/MEG.0000000000002011.
Alexandre Pariente 1, Olivier Chazouilleres 2, Xavier Causse 3, Bertrand Hanslik 4, Jean-Pierre Arpurt 5, Jean Henrion 6, Isabelle Rosa 7, Christophe Renou 8, Armand Garioud 9, Christophe Corpechot 2, DESCRIPT and DESCRIPT Study Groups
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 27. | Male Sex Is Associated With Higher Rates of Liver-Related Mortality in Primary Biliary Cholangitis and Cirrhosis |
| |
Hepatology. 2021 Aug;74(2):879-891. doi: 10.1002/hep.31776. Epub 2021 May 26.
Binu V John 1, Gabriella Aitcheson 2, Kaley B Schwartz 1, Nidah S Khakoo 2, Bassam Dahman 3, Yangyang Deng 3, David Goldberg 4, Paul Martin 4, Tamar H Taddei 5 6, Cynthia Levy 4, David E Kaplan 7 8
|
|
| |
|
|
| |
| 29. | Seladelpar improved measures of pruritus, sleep, and fatigue and decreased serum bile acids in patients with primary biliary cholangitis |
| |
Liver Int. 2021 Aug 17. doi: 10.1111/liv.15039. Online ahead of print.
Andreas E Kremer 1 2, Marlyn J Mayo 3, Gideon Hirschfield 4, Cynthia Levy 5, Christopher L Bowlus 6, David E Jones 7, Alexandra Steinberg 8, Charles A McWherter 8, Yun-Jung Choi 8
|
|
| |
|
|
| |
| 31. | The genetic architecture of primary biliary cholangitis |
| |
Eur J Med Genet. 2021 Jul 23;64(9):104292. doi: 10.1016/j.ejmg.2021.104292.Online ahead of print.
Alessio Gerussi 1, Marco Carbone 2, Cristophe Corpechot 3, Christoph Schramm 4, Rosanna Asselta 5, Pietro Invernizzi 6
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 35. | Baricitinib and primary biliary cholangitis |
| |
J Transl Autoimmun. 2021 Jun 1;4:100107. doi: 10.1016/j.jtauto.2021.100107. eCollection 2021.
Stuart C Gordon 1 2, Sheri Trudeau 3, Arie Regev 4, Jonathan M Uhas 1, Sujatro Chakladar 4, Ana Pinto-Correia 4, Klaus Gottlieb 4, Doug Schlichting 4
|
|
| |
| 36. | Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study |
| |
Am J Gastroenterol. 2021 Jun 23. doi: 10.14309/ajg.0000000000001343. Online ahead of print.
Anna Reig 1 2, Carmen Álvarez-Navascués 3, Mercedes Vergara 2 4, Elena Gómez-Domínguez 5, Adolfo Gallego-Moya 6, Indhira M Pérez-Medrano 7, Emilio Fábrega 8, Manuel Hernández-Guerra 9, Marina Berenguer 2 10 11, Pamela Estevez 12, Ana Arencibia 13, Rosa M Morillas 2 14, Diana Horta 15, Agustín Albillos 2 16, Marta Casado 17, Gema De la Cruz 18, Eva Fernandez-Bonilla 19, Esther Molina 20, Lander Hijona 21, Moises Diago 22, Conrado M Fernández-Rodriguez 23, Jesús M González-Santiago 24, Margarita Sala 2 25, Judith Gómez-Camarero 26, Manuel Romero-Gomez 2 27, Francisco Suárez 28, Victor Vargas 2 29, Carlos Ferre-Aracil 30, Raúl J Andrade 2 31, Nadia Chahri 32, Albert Parés 1 2
Affi
|
|
| |
| 37. | The Serum Proteome and Ursodeoxycholic Acid Response in Primary Biliary Cholangitis |
| |
Hepatology. 2021 Jun 15. doi: 10.1002/hep.32011. Online ahead of print.
Ben Barron-Millar 1, Laura Ogle 1, George Mells 2, Steven Flack 2, Jonathan Badrock 2, Richard Sandford 2, John Kirby 1, Jeremy Palmer 1, Laura Jopson 1, John Brain 1, Graham R Smith 3, Steve Rushton 4, Vinod S Hegade 5, Rebecca Jones 5, Simon Rushbrook 6, Douglas Thorburn 7, Steve Ryder 8, Gideon Hirschfield 9 10, UK-PBC Research Consortium; Jessica K Dyson 1 11, David Jones 1 11
|
|
| |
| 38. | An international genome-wide meta-analysis of primary biliary cholangitis: novel risk loci and candidate drugs |
| |
Heather J Cordell 1, James J Fryett 1, Kazuko Ueno 2, Rebecca Darlay 1, Yoshihiro Aiba 3, Yuki Hitomi 4, Minae Kawashima 4, Nao Nishida 4, Seik-Soon Khor 2, Olivier Gervais 5, Yosuke Kawai 2, Masao Nagasaki 5, Katsushi Tokunaga 2, Ruqi Tang 6, Yongyong Shi 7, Zhiqiang Li 7, Brian D Juran 8, Elizabeth J Atkinson 9, Alessio Gerussi 10, Marco Carbone 10, Rosanna Asselta 11, Angela Cheung 8, Mariza de Andrade 9, Aris Baras 12, Julie Horowitz 12, Manuel A R Ferreira 12, Dylan Sun 12, David E Jones 13, Steven Flack 14, Ann Spicer 14, Victoria L Mulcahy 14, Jinyoung Byan 15, Younghun Han 15, Richard N Sandford 14, Konstantinos N Lazaridis 8, Christopher I Amos 15, Gideon M Hirschfield 16, Michael F Seldin 17, Pietro Invernizzi 10, Katherine A Siminovitch 18, Xiong Ma 6, Minoru Nakamura 3, George F Mells 19, Canadian PBC Consortium, Chinese PBC Consortium, Italian PBC Study Group, Japan-PBC-GWAS Consortium, US PBC Consortium, and UK-PBC Consortium
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 42. | Ursodeoxycholic Acid Response Is Associated With Reduced Mortality in Primary Biliary Cholangitis With Compensated Cirrhosis |
| |
Am J Gastroenterol. 2021 May 13. doi: 10.14309/ajg.0000000000001280. Online ahead of print.
Binu V John 1, Nidah S Khakoo, Kaley B Schwartz, Gabriella Aitchenson, Cynthia Levy, Bassam Dahman, Yangyang Deng, David S Goldberg, Paul Martin, David E Kaplan, Tamar H Taddei
|
|
| |
|
|
| |
| 44. | A Comparison of Prognostic Scores (Mayo, UK-PBC, and GLOBE) in Primary Biliary Cholangitis |
| |
Am J Gastroenterol. 2021 May 4. doi: 10.14309/ajg.0000000000001285. Online ahead of print.
Jorn C Goet 1, Carla F Murillo Perez, Maren H Harms, Annarosa Floreani, Nora Cazzagon, Tony Bruns, Florian Prechter, George N Dalekos, Xavier Verhelst, Nikolaos K Gatselis, Keith D Lindor, Willem J Lammers, Aliya Gulamhusein, Anna Reig, Marco Carbone, Frederik Nevens, Gideon M Hirschfield, Adriaan J van der Meer, Henk R van Buuren, Bettina E Hansen, Albert Parés, GLOBAL PBC Study Group
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 50. | Combination of fibrates with obeticholic acid is able to normalise biochemical liver tests in patients with difficult-to-treat primary biliary cholangitis |
| |
Aliment Pharmacol Ther. 2021 Mar 25. doi: 10.1111/apt.16336. Online ahead of print.
Pierre-Antoine Soret 1, Laurent Lam 1, Fabrice Carrat 1, Lena Smets 2, Thomas Berg 3, Marco Carbone 4, Pietro Invernizzi 4, Vincent Leroy 5, Palak Trivedi 6, Nora Cazzagon 7, Christina Weiler-Normann 8, Laurent Alric 9, Isabelle Rosa-Hezode 10, Alexandra Heurgué 11, Jean-Paul Cervoni 12, Jérôme Dumortier 13, Pascal Potier 14, Olivier Roux 15, Christine Silvain 16, Christophe Bureau 9, Rodolphe Anty 17, Dominique Larrey 18, Cynthia Levy 19, Albert Pares 20, Christoph Schramm 8, Frederik Nevens 2, Olivier Chazouillères 1, Christophe Corpechot 1
|
|
| |
| 51. | Combination of fibrates with obeticholic acid is able to normalise biochemical liver tests in patients with difficult-to-treat primary biliary cholangitis |
| |
Aliment Pharmacol Ther. 2021 Mar 25. doi: 10.1111/apt.16336. Online ahead of print.
Pierre-Antoine Soret 1, Laurent Lam 1, Fabrice Carrat 1, Lena Smets 2, Thomas Berg 3, Marco Carbone 4, Pietro Invernizzi 4, Vincent Leroy 5, Palak Trivedi 6, Nora Cazzagon 7, Christina Weiler-Normann 8, Laurent Alric 9, Isabelle Rosa-Hezode 10, Alexandra Heurgué 11, Jean-Paul Cervoni 12, Jérôme Dumortier 13, Pascal Potier 14, Olivier Roux 15, Christine Silvain 16, Christophe Bureau 9, Rodolphe Anty 17, Dominique Larrey 18, Cynthia Levy 19, Albert Pares 20, Christoph Schramm 8, Frederik Nevens 2, Olivier Chazouillères 1, Christophe Corpechot 1
|
|
| |
|
|
| |
|
|
| |
| 54. | Accuracy of Transient Elastography in assessing fibrosis at diagnosis in naïve patients with Primary Biliary Cholangitis: a dual cut-off approach |
| |
Hepatology. 2021 Mar 16. doi: 10.1002/hep.31810. Online ahead of print.
Laura Cristoferi 1 2 3, Vincenza Calvaruso 4, Diletta Overi 5, Mauro Viganò 6, Cristina Rigamonti 7, Elisabetta Degasperi 8, Vincenzo Cardinale 9, Sara Labanca 10, Nicola Zucchini 11, Anna Fichera 4, Vito Di Marco 4, Monica Leutner 12, Rosanna Venere 13, Antonino Picciotto 10, Martina Lucà 1 2, Giacomo Mulinacci 1 2, Andrea Palermo 1 2, Alessio Gerussi 1 2, Daphne D'Amato 1 2, Sarah Elisabeth O'Donnell 1 2, Federica Cerini 6, Carla De Benedittis 7, Federica Malinverno 1 2, Vincenzo Ronca 1 2, Clara Mancuso 1 2, Nora Cazzagon 14, Antonio Ciaccio 1 2, Donatella Barisani 1, Marco Marzioni 15, Annarosa Floreani 16 17, Domenico Alvaro 9, Eugenio Gaudio 5, Pietro Invernizzi 1 2, Guido Carpino 18, Alessandra Nardi 19, Marco Carbone 1 2, behalf of the Italian PBC Registry
|
|
| |
| 55. | Real-world experience with obeticholic acid in patients with primary biliary cholangitis |
| |
JHEP Rep. 2021 Jan 27;3(2):100248. doi: 10.1016/j.jhepr.2021.100248. eCollection 2021 Apr.
Daphne D'Amato 1, Antonio De Vincentis 2, Federica Malinverno 1, Mauro Viganò 3, Domenico Alvaro 4, Maurizio Pompili 5, Antonino Picciotto 6, Valeria Pace Palitti 7, Maurizio Russello 8, Silvia Storato 9, Marie Graciella Pigozzi 10, Vincenza Calvaruso 11, Elisabetta De Gasperi 12, Ana Lleo 13, Antonino Castellaneta 14, Adriano Pellicelli 15, Nora Cazzagon 16, Annarosa Floreani 16, Luigi Muratori 17, Stefano Fagiuoli 18, Grazia Anna Niro 19, Valentina Feletti 20, Raffaele Cozzolongo 21, Natalia Terreni 22, Marco Marzioni 23, Rinaldo Pellicano 24, Pietro Pozzoni 25, Leonardo Baiocchi 26, Luchino Chessa 27, Floriano Rosina 28, Gaetano Bertino 29, Maria Vinci 30, Anna Morgando 24, Ester Vanni 24, Gaetano Scifo 31, Rodolfo Sacco 32, Maria D'Antò 33, Valentina Bellia 34, Roberto Boldizzoni 35, Silvia Casella 36, Barbara Omazzi 37, Guido Poggi 38, Laura Cristoferi 1, Alessio Gerussi 1, Vincenzo Ronca 1, Rosanna Venere 4, Francesca Ponziani 5, Maria Cannavò 8, Alessandro Mussetto 20, Rosanna Fontana 19, Francesco Losito 21, Evelise Frazzetto 29, Marco Distefano 31, Francesca Colapietro 13, Sara Labanca 6, Giulia Marconi 23, Giuseppe Grassi 26, Giovanni Galati 2, Sarah Elizabeth O'Donnell 1, Clara Mancuso 1, Giacomo Mulinacci 1, Andrea Palermo 1, Ernesto Claar 39, Antonio Izzi 40, Antonio Picardi 2, Pietro Invernizzi 1, Marco Carbone 1, Umberto Vespasiani-Gentilucci 2, Italian PBC Registry and the Club Epatologi Ospedalieri (CLEO)/Associazione Italiana Gastroenterologi ed Endoscopisti Digestivi Ospedalieri (AIGO) PBC Study Group
|
|
| |
|
|
| |
| 57. | X chromosome contribution to the genetic architecture of primary biliary cholangitis |
| |
Gastroenterology. 2021 Mar 3;S0016-5085(21)00466-2. doi: 10.1053/j.gastro.2021.02.061.Online ahead of print.
Gastroenterology. 2021 Mar 3;S0016-5085(21)00466-2. doi: 10.1053/j.gastro.2021.02.061.Online ahead of print.
Rosanna Asselta 1, Elvezia Maria Paraboschi 1, Alessio Gerussi 2, Heather J Cordell 3, George F Mells 4, Richard N Sandford 4, David E Jones 5, Minoru Nakamura 6, Kazuko Ueno 7, Yuki Hitomi 8, Minae Kawashima 8, Nao Nishida 8, Katsushi Tokunaga 9, Masao Nagasaki 10, Atsushi Tanaka 11, Ruqi Tang 12, Zhiqiang Li 13, Yongyong Shi 13, Xiangdong Liu 14, Ma Xiong 12, Gideon Hirschfield 15, Katherine A Siminovitch 16, Canadian-US PBC Consortium; Italian PBC Genetics Study Group; UK-PBC Consortium; Japan PBC-GWAS Consortium; Marco Carbone 2, Giulia Cardamone 1, Stefano Duga 1, M Eric Gershwin 17, Michael F Seldin 17, Pietro Invernizzi 18
|
|
| |
| 58. | Quality of life in patients with primary biliary cholangitis: A cross-geographical comparison |
| |
J Transl Autoimmun. 2021 Jan 6;4:100081. doi: 10.1016/j.jtauto.2021.100081. eCollection 2021.
Lorenzo Montali 1, Andrea Gragnano 1, Massimo Miglioretti 1, Alessandra Frigerio 1, Luca Vecchio 1, Alessio Gerussi 2 3, Laura Cristoferi 2 3, Vincenzo Ronca 2 3, Daphne D'Amato 2 3, Sarah Elizabeth O'Donnell 2 3, Clara Mancuso 2 3, Martina Lucà 2 3, Minami Yagi 4, Anna Reig 5, Laura Jopson 6, Sesé Pilar 5, Dave Jones 6, Albert Pares 5, George Mells 7, Atsushi Tanaka 4, Marco Carbone 2 3, Pietro Invernizzi 2 3
|
|
| |
|
|
| |
|
|
| |
| 61. | Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis |
| |
Clin Gastroenterol Hepatol. 2020 Aug 7;S1542-3565(20)31083-1.doi: 10.1016/j.cgh.2020.08.006. Online ahead of print.
Alessio Gerussi 1, Davide Paolo Bernasconi 2, Sarah Elisabeth O'Donnell 1, Willem J Lammers 3, Henk Van Buuren 3, Gideon Hirschfield 4, Harry Janssen 4, Christophe Corpechot 5, Anna Reig 6, Albert Pares 6, Pier Maria Battezzati 7, Massimo Giovanni Zuin 7, Nora Cazzagon 8, Annarosa Floreani 9, Frederik Nevens 10, Nikolaos Gatselis 11, George Dalekos 11, Marlyn J Mayo 12, Douglas Thorburn 13, Tony Bruns 14, Andrew L Mason 15, Xavier Verhelst 16, Kris Kowdley 17, Adriaan van der Meer 3, Grazia Anna Niro 18, Benedetta Terziroli Beretta-Piccoli 19, Marco Marzioni 20, Luca Saverio Belli 21, Fabio Marra 22, Maria Grazia Valsecchi 2, Keith D Lindor 23, Pietro Invernizzi 1, Bettina E Hansen 24, Marco Carbone 25, Italian PBC Study Group and the GLOBAL PBC Study Group
|
|
| |
| 62. | Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment tool |
| |
Eur J Gastroenterol Hepatol. 2020 Dec 14. doi: 10.1097/MEG.0000000000002029.Online ahead of print.
Carla F Murillo Perez 1 2, Aliya Gulamhusein 1, Marco Carbone 3 4, Palak J Trivedi 5, Adriaan J van der Meer 2, Christophe Corpechot 6, Pier Maria Battezzati 7, Willem J Lammers 2, Nora Cazzagon 4 8, Annarosa Floreani 4 8, Albert Parés 9, Frederik Nevens 10, Ana Lleo 11, Marlyn J Mayo 12, Kris V Kowdley 13, Cyriel Y Ponsioen 14, George N Dalekos 15, Nikolaos K Gatselis 15, Douglas Thorburn 16, Andrew L Mason 17, Harry Janssen 1, Xavier Verhelst 4 18, Tony Bruns 19, Keith D Lindor 20, Olivier Chazouillères 6, Pietro Invernizzi 3 4, Bettina E Hansen 1 21, Gideon M Hirschfield 1, GLOBAL PBC Study Group
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 66. | A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA |
| |
J Hepatol. 2021 Jan 20;S0168-8278(21)00022-2. doi: 10.1016/j.jhep.2021.01.013.Online ahead of print.
Jörn M Schattenberg 1, Albert Pares 2, Kris V Kowdley 3, Michael A Heneghan 4, Stephen Caldwell 5, Daniel Pratt 6, Alan Bonder 7, Gideon M Hirschfield 8, Cynthia Levy 9, John Vierling 10, David Jones 11, Anne Tailleux 12, Bart Staels 12, Sophie Megnien 13, Remy Hanf 13, David Magrez 13, Pascal Birman 13, Velimir Luketic 14
|
|
| |
|
|
| |
|
|
| |
| 69. | Primary biliary cholangitis |
| |
Lancet. 2020 Dec 12;396(10266):1915-1926. doi: 10.1016/S0140-6736(20)31607-X.
Ana Lleo 1, Giu-Qiang Wang 2, Merrill Eric Gershwin 3, Gideon M Hirschfield 4
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 73. | Fibrates for itch (FITCH) in fibrosing cholangiopathies: a double blind, randomized, placebo-controlled trial |
| |
Gastroenterology. 2020 Oct 5;S0016-5085(20)35226-4. doi:10.1053/j.gastro.2020.10.001.Online ahead of print.
Elsemieke de Vries 1, Ruth Bolier 1, Jorn Goet 2, Albert Parés 3, Jef Verbeek 4, Marleen de Vree 5, Joost Drenth 6, Karel van Erpecum 7, Karin van Nieuwkerk 8, Frans van der Heide 5, Nahid Mostafavi 1, Jeltje Helder 1, Cyriel Ponsioen 1, Ronald Oude Elferink 1, Henk van Buuren 2, Ulrich Beuers 9, Netherlands Association for the Study of the Liver - Cholestasis Working Group
|
|
| |
|
|
| |
| 75. | A placebo-controlled randomised trial of budesonide for primary biliary cholangitis following an insufficient response to UDCA |
| |
J Hepatol. 2020 Sep 17;S0168-8278(20)33623-0. doi: 10.1016/j.jhep.2020.09.011.Online ahead of print.
G M Hirschfield 1, U Beuers 2, L Kupcinskas 3, P Ott 4, A Bergquist 5, M Färkkilä 6, M P Manns 7, A Parés 8, U Spengler 9, M Stiess 10, R Greinwald 10, M Pröls 10, D Wendum 11, U Drebber 12, R Poupon 13
|
|
| |
| 76. | Liver Stiffness Measured by Either Magnetic Resonance or Transient Elastography Is Associated With Liver Fibrosis and Is an Independent Predictor of Outcomes Among Patients With Primary Biliary Cholangitis |
| |
J Clin Gastroenterol. 2020 Sep 23. doi: 10.1097/MCG.0000000000001433. Online ahead of print.
Karim T Osman 1, Daniel B Maselli 1, Ilkay S Idilman 2, Daniel J Rowan 3, Jason K Viehman 4, William S Harmsen 4, Denise M Harnois 5, Elizabeth J Carey 6, Andrea A Gossard 1, Nicholas F LaRusso 1, Keith D Lindor 6, Sudhakar K Venkatesh 2, John E Eaton 1
|
|
| |
|
|
| |
|
|
| |
| 79. | Prevalence and long-term outcome of sub-clinical primary sclerosing cholangitis in patients with ulcerative colitis |
| |
Liver Int. 2020 Aug 25. doi: 10.1111/liv.14645. Online ahead of print.
Emma L Culver 1, Helen K Bungay 2, Margaret Betts 2, Colm Forde 2 3, Otto Buchel 4, Charis Manganis 1, Bryan F Warren 5, Jr Fraser Cummings 1 6, Satish Keshav 1, Simon P L Travis 1, Roger W Chapman 1
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 85. | Effects of Primary Biliary Cholangitis on Quality of Life and Health Care Costs in the United Kingdom |
| |
Clin Gastroenterol Hepatol. 2020 Jun 17;S1542-3565(20)30836-3.doi: 10.1016/j.cgh.2020.06.025. Online ahead of print.
Stephen Rice 1, Viviana Albani 2, Dimitrios Minos 3, Gulnar Fattakhova 2, George F Mells 4, Marco Carbone 4, Steven Flack 4, Nikoletta Varvaropoulou 4, Jonathan Badrock 4, Ann Spicer 4, Richard N Sandford 4, Mark D F Shirley 5, Diarmuid Coughlan 2, Gideon Hirschfield 6, Simon D Taylor-Robinson 7, UK-PBC Consortium; Luke Vale 2, David E J Jones 8
|
|
| |
| 86. | Risk Factors for Complications After Cholecystectomy for Common Bile Duct Stones: An EAST Multicenter Study |
| |
Surgery. 2020 Jul;168(1):62-66. doi: 10.1016/j.surg.2020.04.011. Epub 2020 May 26.
Brett M Tracy 1, Cameron W Paterson 2, Denise M Torres 3, Katelyn Young 3, Beth R Hochman 4, Martin D Zielinski 5, Sigrid K Burruss 6, Michelle B Mulder 7, Daniel Dante Yeh 7, Rondi B Gelbard 2, EAST Retained Common Bile Duct Stones Study Group
- EAST Retained Common Bile Duct Stones Study Group:
Beth Hochman, Natasha Coleman, Anna Goldenberg-Sandau, Jennifer Schweinsburg, Rondi Gelbard, Cameron Paterson, Brett Tracy, Rondi Gelbard, Cameron Paterson, Brett Tracy, Katelyn Young, Denise Torres, David Morris, Ashley Boyer, Sigrid Burruss, Xian Luo-Owen, Daniel Cullinane, Laura Cullinane, April Mendoza, Apostolos Gaitanidis, Martin Zielinski, Maraya Camazine, Shaneeta Johnson, Michelle Mulder, Rishi Rattan, D Dante Yeh, Jonathan Saxe, Daniel Kinstedt, Amanda Celii, Kiran Venincasa
|
|
| |
|
|
| |
|
|
| |
| 89. | Pregnancy Outcomes in Women With Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: A Retrospective Cohort Study |
| |
BJOG. 2020 Jun;127(7):876-884. doi: 10.1111/1471-0528.16119. Epub 2020 Mar 8.
M Cauldwell 1, F L Mackie 2, P J Steer 1, M A Henehghan 3, J H Baalman 4, J Brennand 5, T Johnston 2, S Dockree 6, C Hedley 7, S Jarvis 8, S Khan 9, F M McAuliffe 4, L Mackillop 6, L Penna 7, B Smith 10, P Trivedi 9, S Verma 11 12, R Westbrook 13, S Winifield 14, C Williamson 15
|
|
| |
|
|
| |
| 91. | Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase |
| |
Am J Gastroenterol. 2020 Feb 20. doi: 10.14309/ajg.0000000000000557. Online ahead of print.
Carla F Murillo Perez 1 2, Maren H Harms 2, Keith D Lindor 3, Henk R van Buuren 2, Gideon M Hirschfield 1, Christophe Corpechot 4, Adriaan J van der Meer 2, Jordan J Feld 1, Aliya Gulamhusein 1, Willem J Lammers 2, Cyriel Y Ponsioen 5, Marco Carbone 6, Andrew L Mason 7, Marlyn J Mayo 8, Pietro Invernizzi 6, Pier Maria Battezzati 9, Annarosa Floreani 10, Ana Lleo 11, Frederik Nevens 12, Kris V Kowdley 13, Tony Bruns 14 15, George N Dalekos 16, Nikolaos K Gatselis 16, Douglas Thorburn 17, Palak J Trivedi 18, Xavier Verhelst 19, Albert Parés 20, Harry L A Janssen 1, Bettina E Hansen 1 21, GLOBAL PBC Study Group
|
|
| |
|
|
| |
| 93. | Ursodeoxycholic Acid Treatment Preferentially Improves Overall Survival Among African Americans With Primary Biliary Cholangitis |
| |
Am J Gastroenterol. 2020 Feb;115(2):262-270. doi: 10.14309/ajg.0000000000000512.
Stuart C Gordon 1, Kuan-Han Hank Wu 2, Keith Lindor 3, Christopher L Bowlus 4, Carla V Rodriguez 5 6, Heather Anderson 7, Joseph A Boscarino 8, Sheri Trudeau 2, Loralee B Rupp 9, Irina V Haller 10, Robert J Romanelli 11, Jeffrey J VanWormer 12, Mark A Schmidt 13, Yihe G Daida 14, Amandeep Sahota 15, Jennifer Vincent 16, Talan Zhang 1, Jia Li 1, Mei Lu 1, FOLD Investigators
|
|
| |
|
|
| |
|
|
| |
| 96. | Pruritus Is Common and Undertreated in Patients With Primary Biliary Cholangitis in the United Kingdom |
| |
Clin Gastroenterol Hepatol. 2019 Jun;17(7):1379-1387.e3. doi: 10.1016/j.cgh.2018.12.007.Epub 2018 Dec 14.
Vinod S Hegade 1, George F Mells 2, Holly Fisher 3, Stuart Kendrick 4, Julia DiBello 5, Kim Gilchrist 5, Graeme J Alexander 2, Gideon M Hirschfield 6, Richard N Sandford 7, David E J Jones 8, UK-PBC Consortium
|
|
| |
| 97. | Effects of Age and Sex of Response to Ursodeoxycholic Acid and Transplant-free Survival in Patients With Primary Biliary Cholangitis |
| |
Gastroenterol Hepatol. 2019 Sep;17(10):2076-2084.e2. doi: 10.1016/j.cgh.2018.12.028.Epub 2019 Jan 4.
Angela C Cheung 1, Willem J Lammers 2, Carla F Murillo Perez 3, Henk R van Buuren 2, Aliya Gulamhusein 3, Palak J Trivedi 4, Konstantinos N Lazaridis 1, Cyriel Y Ponsioen 5, Annarosa Floreani 6, Gideon M Hirschfield 3, Christophe Corpechot 7, Marlyn J Mayo 8, Pietro Invernizzi 9, Pier Maria Battezzati 10, Albert Parés 11, Frederik Nevens 12, Douglas Thorburn 13, Andrew L Mason 14, Marco Carbone 9, Kris V Kowdley 15, Tony Bruns 16, George N Dalekos 17, Nikolaos K Gatselis 17, Xavier Verhelst 18, Keith D Lindor 19, Ana Lleo 9, Raoul Poupon 7, Harry L A Janssen 3, Bettina E Hansen 20, Global PBC Study Group
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 122. | Steatohepatitis and liver fibrosis are predicted by the characteristics of very low density lipoprotein in nonalcoholic fatty liver disease |
| |
Jiang ZG1, Tapper EB1, Connelly MA2, Pimentel CM1, Feldbrügge L1, Kim M3, Krawczyk S3, Afdh Al N1, Robson SC1, Herman M3, Otvos JD2, Mukamal KJ4, Lai M1. Liver Int. 2016 Jan 27. doi: 10.1111/liv.13076. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 128. | Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study |
| |
Armstrong MJ1, Gaunt P2, Aithal GP3, Barton D4, Hull D4, Parker R1, Hazlehurst JM5, Guo K4; LEAN trial team, Abouda G6, Aldersley MA7, Stocken D8, Gough SC5, Tomlinson JW5, Brown RM9, Hübscher SG10, Newsome PN11. Lancet. 2015 Nov 19. pii: S0140-6736(15)00803-X. doi: 10.1016/S0140-6736(15)00803-X. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
|
|
| |
| 132. | Non-alcoholic Steatohepatitis is Associated with Increased Mortality in Obese Patients Undergoing Bariatric Surgery |
| |
Goossens N1, Hoshida Y2, Song WM3, Jung M4, Morel P4, Nakagawa S5, Zhang B3, Frossard JL6, Spahr L6, Friedman SL5, Negro F7, Rubbia-Brandt L8, Giostra E6. Clin Gastroenterol Hepatol. 2015 Oct 19. pii: S1542-3565(15)01406-8. doi: 10.1016/j.cgh.2015.10.010. [Epub ahead of print] |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 143. | Hepatic Injury in Nonalcoholic Steatohepatitis Contributes to Altered Intestinal Permeability |
| |
Luther J1, Garber JJ1, Khalili H1, Dave M2, Bale SS3, Jindal R3, Motola DL1, Luther S1, Bohr S3, Jeoung SW1, Deshpande V1, Singh G4, Turner JR4, Yarmush ML3, Chung RT1, Patel SJ3. Cell Mol Gastroenterol Hepatol. 2015 Mar;1(2):222-232. |
|
| |
|
|
| |
|
|
| |
|
|
| |
| 147. | Hepatic Injury in Nonalcoholic Steatohepatitis Contributes to Altered Intestinal Permeability |
| |
Luther J1, Garber JJ1, Khalili H1, Dave M2, Bale SS3, Jindal R3, Motola DL1, Luther S1, Bohr S3, Jeoung SW1, Deshpande V1, Singh G4, Turner JR4, Yarmush ML3, Chung RT1, Patel SJ3. Cell Mol Gastroenterol Hepatol. 2015 Mar;1(2):222-232. |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 156. | Bile Acid Signaling: Mechanism for Bariatric Surgery, Cure for NASH? |
| |
Kohli R1, Myronovych A, Tan BK, Salazar-Gonzalez RM, Miles L, Zhang W, Oehrle M, Sandoval DA, Ryan KK, Seeley RJ, Setchell KD. Dig Dis. 2015;33(3):440-6. doi: 10.1159/000371699. Epub 2015 May 27. |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
| |
|
|
|
|
| |
|
| |
|
